how much tirzepatide should you start with Dosage Guide and Chart for Weight Loss At a glance factsheet: Tirzepatide
Description
Tirzepatide is a dual GIP/GLP-1 receptor agonist administered as a weekly subcutaneous injection, producing up to 20.9% weight loss at 72 weeks in Phase 3 trials
Zepbound contains the active ingredient tirzepatide, which works by mimicking naturally occurring hormones called incretins
In my practice, Ive seen that women experiencing perimenopause or thyroid imbalance often need a multifaceted approach
It is recommended to take 10.5 grams three times daily before meals to promote weight loss
